Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The document's conclusion cannot be provided because the content is not in a readable format.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

CAG repeat numbers in the AR gene likely don't affect hair loss in Korean men.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Serial Excision Technique improves appearance and quality of life for cicatricial alopecia patients.

A patient with a rare disease had a unique genetic mutation linked to their symptoms.

Ascorbyl Tetraisopalmitate penetrates skin better in the stratum corneum than in the infundibulum.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Very-long-chain acyl-CoA synthetases and fatty acid transport proteins play key roles in fatty acid metabolism and lipid processing in different tissues.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.